Manager, Global Markets (Vaccines) – Clinton Health Access Initiative (CHAI) – United States
The Clinton Health Access Initiative (CHAI) is a global health organization committed to strengthening integrated health systems in the developing world and expanding access to preventative health interventions like vaccines, as well as care and treatment for HIV/AIDS, malaria and other diseases. Based on the premise that business-oriented strategy can facilitate solutions to global health challenges, CHAI acts as a catalyst to mobilize new resources and optimize the impact of these resources to save lives, via improved organization of commodity markets and more effective national and sub-national level management. Currently, CHAI partners with governments in more than 25 countries, while more than 70 countries directly benefit from the low-priced drugs, diagnostic tests, and vaccines agreements that CHAI has negotiated.
Immunization is widely acknowledged as the most cost-effective and focused disease intervention, and yet each year an estimated three million children under the age of five lose their lives to preventable illnesses. A majority of these deaths occur in low-income countries, where poverty and lack of affordability prevent access to life-saving vaccines.
There is an unprecedented wave of new vaccines expected to become available within the next decade that could transform the global burden of disease, and CHAI is applying the techniques it has used successfully to improve access to HIV/AIDS and malaria treatment in developing countries to achieve the same for essential vaccines and vaccine cold chain equipment. In order to increase vaccine cold chain capacity to cater for the introduction of new vaccines, national governments and donors will expect to spend up to USD$1.7 billion to purchase and operate cold chain equipment over the next 10 years. Given the current difficult financial climate, governments and donors may be unable to meet the escalating cost burden. As a result, the pricing and market conditions of new and existing vaccines and vaccine cold chain equipment will be a critical determinant of coverage levels and, therefore, health impact in the coming years.
Driven by the belief that all children deserve fair equitable access to the latest life-saving vaccines, CHAI has already begun to work with key partners to negotiate price reductions for major vaccines. This work has resulted in a reduction in the price of rotavirus vaccine by two-thirds, resulting in savings of over USD$650M for global donors and governments over 5 years. Efforts on other antigens and cold chain equipment are currently underway. By working with key stakeholders, the CHAI Global Vaccine Markets program aims to support the achievement of affordable yet commercially sustainable vaccine and vaccine cold chain equipment prices, thereby increasing value for money and enabling accelerated introduction of new vaccines in developing countries.
Selected news about CHAI work on access in vaccines and other areas:
- WHO press release, April 2013
- WHO press release, September 2012
- GAVI press release, April 2012
- GSK press release, June 2011
LOCATION: Flexibility for placement in CHAI programmatic country per country
As part of the Global Markets team, the Manager will lead a team to achieve affordable yet sustainable global vaccine prices and supply, including but not limited to the following responsibilities:
- Manage a remote team of 3-4 Analysts/Associates on projects to improve vaccine accessibility to low-income countries
- Lead analysis on vaccine market dynamics including demand forecasting, production capacity of key manufacturers, production technologies and their costs, cost reduction strategies, product development and manufacturing timelines, and manufacturers’ vaccine development and marketing strategies
- Lead analysis of vaccine cost of goods sold and other analysis as needed in vaccine price negotiations for low-income countries
- Screen vaccine suppliers, examining their product portfolio and pipeline, regulatory status and potential, and production capacity, among other components
- Manage relationships with suppliers that have the potential to become significant, quality-assured producers of relevant new cold chain equipment for developing markets
- Build and maintain these relationships by providing valuable market insights and contacts, offering targeted support and guidance to navigate regulatory and procurement processes
- Lead relationship management with key donors such as the Bill and Melinda Gates foundation
- Lead preparations of presentations, reports, and other analyses to inform global policy and increase the evidence base for high-impact interventions
- Develops concept notes and initiates new projects
- Manages contract and budget of key grants
- Any other duties as required by the Director, Global Markets Team
- 20-30% International travel required
- Minimum 6 years of experience
- Previous experience managing teams
- Excellent oral and written communication skills
- Ability to work independently and effectively in high-pressure, fast-paced environment and handle multiple tasks simultaneously
- Exceptional problem-solving and critical thinking
- Entrepreneurial mindset, including ability to work independently, self-motivate, and propose and implement new initiatives
- Experience working with vaccine or cold chain equipment manufacturers is a strong plus
- Candidates with experience working in a consulting or investment bank are encouraged to apply
- Advanced degrees in management, public health, or other relevant fields